Cardinal Health, Inc. (CAH) Q4 FY26 Earnings Call

Strong Pharma-led momentum supports FY27 growth, but Q4 included a material non-recurring tariff benefit.

Q4 FY26 results, source: company transcript and SEC filings
QuarterQ4 FY26
Call date2026-08-11
Length61 minutes
EPS$2.91
EPS consensus$2.42
Revenue$65.6B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26 · Q4 FY25 · Q3 FY25 · Q2 FY25 · Q1 FY25 · Q2 FY22

All CAH earnings · Back to CAH overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.